BIOMAT Database Logo BIOMAT Database Logo

[Isolation, purification and substrate specificity of aminoglycoside phosphotransferase from Escherichia coli 182]. 1976

V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
[Aminoglycoside-3'-phosphotransferase I from aminoglycoside-polyresistant strain E. coli 182].
December 1978, Biokhimiia (Moscow, Russia),
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Broad spectrum aminoglycoside phosphotransferase type III from Enterococcus: overexpression, purification, and substrate specificity.
June 1994, Biochemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
A nucleotide phosphotransferase from Escherichia coli. Purification and properties.
July 1973, Biochemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Purification and substrate specificity of a phenylalanine-activating enzyme from Escherichia coli 9723.
September 1962, The Journal of biological chemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.
September 1981, Antimicrobial agents and chemotherapy,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Transfer ribonucleic acid nucleotidyltransferase from Escherichia coli. II. Purification, physical properties, and substrate specificity.
March 1971, The Journal of biological chemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Revisiting the nucleotide and aminoglycoside substrate specificity of the bifunctional aminoglycoside acetyltransferase(6')-Ie/aminoglycoside phosphotransferase(2'')-Ia enzyme.
December 2012, The Journal of biological chemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
ADENOSINE TRIPHOSPHATE: GUANOSINE MONOPHOSPHATE PHOSPHOTRANSFERASE. PARTIAL PURIFICATION AND SUBSTRATE SPECIFICITY.
January 1965, The Journal of biological chemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Substrate specificity of CTP synthetase from Escherichia coli.
August 1982, European journal of biochemistry,
V L Ganelin, and Iu O Sazykin, and I O Razlogova, and L E Mogilevichik, and S M Navashin
Ribokinase from E. coli: expression, purification, and substrate specificity.
September 2006, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!